Treatment of Crimean-Congo hemorrhagic fever
- 3 December 2007
- journal article
- review article
- Published by Elsevier
- Vol. 78 (1) , 125-131
- https://doi.org/10.1016/j.antiviral.2007.11.002
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Viral Load as a Predictor of Outcome in Crimean-Congo Hemorrhagic FeverClinical Infectious Diseases, 2007
- Haemophagocytosis in a patient with Crimean–Congo haemorrhagic feverJournal of Medical Microbiology, 2007
- Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisitedClinical Microbiology & Infection, 2006
- Crimean-Congo haemorrhagic feverThe Lancet Infectious Diseases, 2006
- Evaluation of Serum Levels of Interleukin (IL)–6, IL‐10, and Tumor Necrosis Factor–α in Patients with Crimean‐Congo Hemorrhagic FeverThe Journal of Infectious Diseases, 2006
- Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cellsJournal of Medical Virology, 2005
- Characteristics of Patients with Crimean-Congo Hemorrhagic Fever in a Recent Outbreak in Turkey and Impact of Oral Ribavirin TherapyClinical Infectious Diseases, 2004
- Human MxA Protein Inhibits the Replication of Crimean-Congo Hemorrhagic Fever VirusJournal of Virology, 2004
- ISG20, a New Interferon-induced RNase Specific for Single-stranded RNA, Defines an Alternative Antiviral Pathway against RNA Genomic VirusesJournal of Biological Chemistry, 2003
- IMPORTANCE OF DOSE OF NEUTRALISING ANTIBODIES IN TREATMENT OF ARGENTINE HAEMORRHAGIC FEVER WITH IMMUNE PLASMAThe Lancet, 1984